The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

Jana de Boniface; Johan Ahlgren; Yvette Andersson; Leif Bergkvist; Jan Frisell; Dan Lundstedt; Roger Olofsson Bagge; Lisa Rydén; Malin Sund

doi:10.1007/s10549-020-05537-1

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

Jana de Boniface, Johan Ahlgren, Yvette Andersson, Leif Bergkvist, Jan Frisell, Dan Lundstedt, Roger Olofsson Bagge, Lisa Rydén, Malin Sund

Department of Obstetrics and Gynecology

Research output: Contribution to journal › Original Article › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	167-176
Journal	BREAST CANCER RESEARCH AND TREATMENT
Volume	180
Issue number	1
DOIs	https://doi.org/10.1007/s10549-020-05537-1
Publication status	Published - 2020

Keywords

AXILLARY DISSECTION
PHASE-III
RADIOTHERAPY
SURVIVAL
SURGERY
BIOPSY
WOMEN

Access to Document

10.1007/s10549-020-05537-1

Cite this

de Boniface, J., Ahlgren, J., Andersson, Y., Bergkvist, L., Frisell, J., Lundstedt, D., Olofsson Bagge, R., Rydén, L., & Sund, M. (2020). The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. BREAST CANCER RESEARCH AND TREATMENT , 180(1), 167-176. https://doi.org/10.1007/s10549-020-05537-1

de Boniface, Jana ; Ahlgren, Johan ; Andersson, Yvette et al. / The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT 2020 ; Vol. 180, No. 1. pp. 167-176.

@article{c5d13905c8d447e696b4df2f7cea7e09,

title = "The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.",

keywords = "AXILLARY DISSECTION, PHASE-III, RADIOTHERAPY, SURVIVAL, SURGERY, BIOPSY, WOMEN",

author = "{de Boniface}, Jana and Johan Ahlgren and Yvette Andersson and Leif Bergkvist and Jan Frisell and Dan Lundstedt and {Olofsson Bagge}, Roger and Lisa Ryd{\'e}n and Malin Sund",

note = "Roland Reitsamer, Austria (studygroup)",

year = "2020",

doi = "10.1007/s10549-020-05537-1",

language = "English",

volume = "180",

pages = "167--176",

journal = "BREAST CANCER RESEARCH AND TREATMENT ",

issn = "0167-6806",

number = "1",

}

de Boniface, J, Ahlgren, J, Andersson, Y, Bergkvist, L, Frisell, J, Lundstedt, D, Olofsson Bagge, R, Rydén, L & Sund, M 2020, 'The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.', BREAST CANCER RESEARCH AND TREATMENT , vol. 180, no. 1, pp. 167-176. https://doi.org/10.1007/s10549-020-05537-1

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. / de Boniface, Jana; Ahlgren, Johan; Andersson, Yvette et al.
In: BREAST CANCER RESEARCH AND TREATMENT , Vol. 180, No. 1, 2020, p. 167-176.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

AU - de Boniface, Jana

AU - Ahlgren, Johan

AU - Andersson, Yvette

AU - Bergkvist, Leif

AU - Frisell, Jan

AU - Lundstedt, Dan

AU - Olofsson Bagge, Roger

AU - Rydén, Lisa

AU - Sund, Malin

N1 - Roland Reitsamer, Austria (studygroup)

PY - 2020

Y1 - 2020

KW - AXILLARY DISSECTION

KW - PHASE-III

KW - RADIOTHERAPY

KW - SURVIVAL

KW - SURGERY

KW - BIOPSY

KW - WOMEN

U2 - 10.1007/s10549-020-05537-1

DO - 10.1007/s10549-020-05537-1

M3 - Original Article

C2 - 31989379

SN - 0167-6806

VL - 180

SP - 167

EP - 176

JO - BREAST CANCER RESEARCH AND TREATMENT

JF - BREAST CANCER RESEARCH AND TREATMENT

IS - 1

ER -

de Boniface J, Ahlgren J, Andersson Y, Bergkvist L, Frisell J, Lundstedt D et al. The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. BREAST CANCER RESEARCH AND TREATMENT . 2020;180(1):167-176. doi: 10.1007/s10549-020-05537-1